Enorama Pharma
0.28 SEK
Less than 1K followers
ERMA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+5.66 %
-24.12 %
-81.88 %
-85.34 %
-90.00 %
-90.94 %
-92.81 %
-98.74 %
-95.60 %
Enorama Pharma is a pharmaceutical company. The company's operations are focused on producing and developing medical nicotine chewing gum. The products are sold mainly through retailers who sell the product under their own brand. The largest market is found in the Nordic region, but with a share of sales exported globally. Enorama Pharma was founded in 2006 and the headquarters are located in Malmö.
Read moreMarket cap
20.88M SEK
Turnover
-
Revenue
2.74M
EBIT %
-2,293.17 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
20/5
2026
Interim report Q1'26
19/8
2026
Interim report Q2'26
18/11
2026
Interim report Q3'26
All
Press releases
ShowingAll content types
Enorama Pharma: KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA, TILLIKA FÖRSTA KONTROLLSTÄMMA, I ENORAMA PHARMA AB (PUBL)
Enorama Pharma: PRESS RELEASE FROM THE EXTRAORDINARY GENERAL MEETING, AND FIRST CONTROL MEETING, IN ENORAMA PHARMA AB (PUBL)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools